Stocks · News reference
8-K filing — Lexaria Bioscience Corp. (LEXX)
Filed: 2026-09-09 AccNo: 0001640334-26-001468 Size: 518 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Lexaria Bioscience Says Australian Tax Refund And Institutional Financing Priced At $12.92/Share Yielded $7.9M Net, About $4.60/Share In Cash On 2.1 Million Shares Outstanding; Says No Further Financings Planned In 2026
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's after-market session. The company's market cap stands at $1.4 billion. The company's, Q4 earnings came out today.